Huawei says it won't make drugs, aims to be computing base for AI drug discovery

The president of Huawei's pharmaceutical unit said at a Nanjing conference on October 24 that the company will not develop drugs or build pipelines, but will supply computing, storage, networking and toolchains for AI drug discovery. Partner projects are deploying clusters of about 100 accelerator cards, while Huawei's SuperPoD links 1,024 cards.

• Huawei will not build its own drug pipelines
• Partner projects deploy clusters of about 100 accelerators
• SuperPoD links 1,024 cards for model training
• Model partners include DP Technology, StoneWise and MoleculeMind